Dr Amir Khan has insisted there is ‘no proven link’ between the Oxford AstraZeneca coronavirus vaccine and blood clots.
There have been fears that the Covid-19 jab could be linked to rare blood clots, with the University of Oxford pausing a trial in children and teenagers over the worries.
Ahead of a review from the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), Dr Amir urged the public to still go in for their vaccines.
Appearing on today’s instalment of Lorraine, the health expert said there is ‘no connection’ to be found.
‘The MHRA, our governing body that looks into the safety of medicines, are looking into the possible connection between the Oxford AstraZeneca vaccine and very, very rare blood clots,’ he told host Cat Deeley – who is filling in for Lorraine Kelly.
‘At the moment there is no connection to be found and lots of people have been looking into it. But it’s just a precautionary measure.
Dr Amir Khan explained the blood clots are ‘very, very rare’ (Picture: ITV)
‘[The roll out] is continuing, It’s very, very rare, these blood clots. If there’s a link between the vaccine and them, it hasn’t been proven yet. Certainly having the vaccine, the benefits of having the vaccine outweigh any potential risk.
‘You’re much more likely to get a clot, or even die from Covid, than you are to get a clot from the vaccine.’
He added: ‘Absolutely go for your second vaccine, there is no proven link as of yet between the vaccine and any clots. It’s really important and the benefits outweigh any risk.’
Dr Amir’s words come after it was revealed that the University of Oxford had paused a trial in children and teenagers over the blood clot fears.
Boris Johnson advised the public to go in for their second AstraZeneca vaccine if they’re called (Picture: AP)
A spokesperson said the move was a precaution and that none of the young people involved in the trial have had health issues.
‘Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial,’ they said.
‘Parents and children should continue to attend all scheduled visits and can contact the trial sites if they have any questions.’
The MHRA said it had identified 30 cases of rare blood clot events – with seven deaths – out of 18.1 million doses of the AstraZeneca jab administered up to March 24, in the UK.
Boris Johnson later defended the jab, during a visit to the pharmaceutical giant’s manufacturing plant in Macclesfield.
‘The best thing people should do is look at what the MHRA say, our independent regulator – that’s why we have them, that’s why they are independent,’ he said.
‘Their advice to people is to keep going out there, get your jab, get your second jab.’
Lorraine continues on weekday mornings, at 9am, on ITV.
Credit: Original article published here.